Tricopharming (Biotech Tricopharming Research) has closed a collaboration agreement with Livisto for the exclusive distribution in Spain of its product Artennua®, 100% vegetable complementary food capsules, which will also be available on the market with a new formulation. The objective of the collaboration is to expand the Artennua® brand throughout Spain, and preserve its identity…
Artennua is a standardised version of Artemisia annua, a medicinal plant used for centuries in Chinese Medicine that is the only natural source of artemisinin. Artemisinin is the molecule recommended by the WHO to treat malaria.
Artemisinin, its derivatives, and other secondary metabolites contained in the plant Artemisia annua, have the potential to treat a broad range of diseases and afflictions. However, Artemisia annua produces very low quantities of artemisinin, and thus, its global supply is limited.
As scientists and social entrepreneurs, we have used natural plant biopharming methods to improve some characteristics of the Artemisia annua plant, meaning its therapeutic properties can now be exploited more extensively.